NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE99857 Query DataSets for GSE99857
Status Public on Dec 01, 2017
Title 22Rv1 in vivo progression model
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Purpose: Even in last stage of metastatic castration-resistant prostate cancer, androgen receptor (AR) signaling remains active.To derive high metastatic prostate cancer (PCa), we labeled AR-positive but castration-resistant 22Rv1 PCa cells with luciferase gene (22Rv1-Luc2) and these cells were orthotopically implanted in mouse prostate for spontaneous progression.
Methods: 2 × 10^5 of luciferase-expressing 22Rv1 cells (22Rv1-Luc2) cells were implanted in the anterior prostate of nude mice. After 12-14 weeks, the host mice were necropsied and the metastases from lumbar lymph nodes and primary tumors were dissected under laminar flow. Tumor tissues were minced using sterile scalpels and further digested with Collagenase D for 1 h. The lymph node metastatic cancer cells, named 22Rv1-M1, were orthotopically reimplanted in nude mice. At 12 weeks, the secondary metastases were isolated in the lumbar lymph nodes and designated as 22Rv1-M2 cells. Suspension of 1 × 10^6 22Rv1-M2 cells in DPBS was injected into nude mice through the tail vein, and mice developed metastases (22Rv1-M3) after 6 week. This procedure was repeated once to attain the 22Rv1-M4.
Results: 22Rv1-derived metastatic cell lines exhibit increased in vitro and in vivo invasion activity as the progression from 22Rv1 to M4. Transcriptomic analysis of genome-wide gene expression in the M4 tumors reveal the unique gene expression profile compared to 22Rv1 tumors.
Conclusions: Transcriptomic data provide the gene network for decoding the mechanism of PCa metastasis.
 
Overall design Transcriptomic profiles of the 22Rv1-Luc2 cells, 3 individual 22Rv1-derived tumor samples and 3 individual 22Rv1-M4-derived tumor samples were sequenced using RNAseq. SRA Study accession:SRP108867; BioProject accession: PRJNA389750
 
Contributor(s) Tsai C, Hsiao P
Citation(s) 27485450
BioProject PRJNA389750
Submission date Jun 09, 2017
Last update date May 15, 2019
Contact name Chin-Hsien Tsai
E-mail(s) tch@gate.sinica.edu.tw
Organization name Academia Sinica
Department ABRC
Street address Nan-Kang
City Taipei
State/province Others
ZIP/Postal code 11529
Country Taiwan
 
Platforms (1)
GPL15456 Illumina HiScanSQ (Homo sapiens)
Samples (7)
GSM2656057 22Rv1-Luc2
GSM2656058 22Rv1-tumor_01
GSM2656059 22Rv1-tumor_02
Relations
SRA SRP108867

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE99857_genes.fpkm_table.txt.gz 1.2 Mb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap